KATHERINE HULS: Open Payments
NPI 1679012017 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 21 payments from 10 companies in 2025. Trend: 2023 $95 · 2024 $418 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $78 |
| Daiichi Sankyo Inc. | 3 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $63 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| Incyte Corporation | 2 | $45 |
| SOBI, INC | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Tempus AI, Inc | 2 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Nubeqa, FRUZAQLA, DATROWAY, Vonjo, SCEMBLIX, LYNPARZA, MONJUVI, XT CDX.
Industry payments across AZ — which companies pay providers there.
